275 related articles for article (PubMed ID: 30381401)
1. Platelet CD36 signaling through ERK5 promotes caspase-dependent procoagulant activity and fibrin deposition in vivo.
Yang M; Kholmukhamedov A; Schulte ML; Cooley BC; Scoggins NO; Wood JP; Cameron SJ; Morrell CN; Jobe SM; Silverstein RL
Blood Adv; 2018 Nov; 2(21):2848-2861. PubMed ID: 30381401
[TBL] [Abstract][Full Text] [Related]
2. Platelet CD36 promotes thrombosis by activating redox sensor ERK5 in hyperlipidemic conditions.
Yang M; Cooley BC; Li W; Chen Y; Vasquez-Vivar J; Scoggins NO; Cameron SJ; Morrell CN; Silverstein RL
Blood; 2017 May; 129(21):2917-2927. PubMed ID: 28336528
[TBL] [Abstract][Full Text] [Related]
3. CD36 and ERK5 link dyslipidemia to apoptotic-like platelet procoagulant function.
Yang M; Silverstein RL
Curr Opin Hematol; 2019 Sep; 26(5):357-365. PubMed ID: 31261174
[TBL] [Abstract][Full Text] [Related]
4. Oxidized LDL activates blood platelets through CD36/NOX2-mediated inhibition of the cGMP/protein kinase G signaling cascade.
Magwenzi S; Woodward C; Wraith KS; Aburima A; Raslan Z; Jones H; McNeil C; Wheatcroft S; Yuldasheva N; Febbriao M; Kearney M; Naseem KM
Blood; 2015 Apr; 125(17):2693-703. PubMed ID: 25710879
[TBL] [Abstract][Full Text] [Related]
5. A specific CD36-dependent signaling pathway is required for platelet activation by oxidized low-density lipoprotein.
Chen K; Febbraio M; Li W; Silverstein RL
Circ Res; 2008 Jun; 102(12):1512-9. PubMed ID: 18497330
[TBL] [Abstract][Full Text] [Related]
6. Cysteine sulfenylation by CD36 signaling promotes arterial thrombosis in dyslipidemia.
Yang M; Li W; Harberg C; Chen W; Yue H; Ferreira RB; Wynia-Smith SL; Carroll KS; Zielonka J; Flaumenhaft R; Silverstein RL; Smith BC
Blood Adv; 2020 Sep; 4(18):4494-4507. PubMed ID: 32946569
[TBL] [Abstract][Full Text] [Related]
7. Coated platelets function in platelet-dependent fibrin formation via integrin αIIbβ3 and transglutaminase factor XIII.
Mattheij NJ; Swieringa F; Mastenbroek TG; Berny-Lang MA; May F; Baaten CC; van der Meijden PE; Henskens YM; Beckers EA; Suylen DP; Nolte MW; Hackeng TM; McCarty OJ; Heemskerk JW; Cosemans JM
Haematologica; 2016 Apr; 101(4):427-36. PubMed ID: 26721892
[TBL] [Abstract][Full Text] [Related]
8. Oxidized low-density lipoproteins induce rapid platelet activation and shape change through tyrosine kinase and Rho kinase-signaling pathways.
Wraith KS; Magwenzi S; Aburima A; Wen Y; Leake D; Naseem KM
Blood; 2013 Jul; 122(4):580-9. PubMed ID: 23699602
[TBL] [Abstract][Full Text] [Related]
9. Dual mechanism of integrin αIIbβ3 closure in procoagulant platelets.
Mattheij NJ; Gilio K; van Kruchten R; Jobe SM; Wieschhaus AJ; Chishti AH; Collins P; Heemskerk JW; Cosemans JM
J Biol Chem; 2013 May; 288(19):13325-36. PubMed ID: 23519467
[TBL] [Abstract][Full Text] [Related]
10. PCSK9 (Proprotein Convertase Subtilisin/Kexin 9) Enhances Platelet Activation, Thrombosis, and Myocardial Infarct Expansion by Binding to Platelet CD36.
Qi Z; Hu L; Zhang J; Yang W; Liu X; Jia D; Yao Z; Chang L; Pan G; Zhong H; Luo X; Yao K; Sun A; Qian J; Ding Z; Ge J
Circulation; 2021 Jan; 143(1):45-61. PubMed ID: 32988222
[TBL] [Abstract][Full Text] [Related]
11. Vav guanine nucleotide exchange factors link hyperlipidemia and a prothrombotic state.
Chen K; Li W; Major J; Rahaman SO; Febbraio M; Silverstein RL
Blood; 2011 May; 117(21):5744-50. PubMed ID: 21427288
[TBL] [Abstract][Full Text] [Related]
12. Soluble fibrin causes an acquired platelet glycoprotein VI signaling defect: implications for coagulopathy.
Lee MY; Verni CC; Herbig BA; Diamond SL
J Thromb Haemost; 2017 Dec; 15(12):2396-2407. PubMed ID: 28981200
[TBL] [Abstract][Full Text] [Related]
13. Platelet activation by oxidized low density lipoprotein is mediated by CD36 and scavenger receptor-A.
Korporaal SJ; Van Eck M; Adelmeijer J; Ijsseldijk M; Out R; Lisman T; Lenting PJ; Van Berkel TJ; Akkerman JW
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2476-83. PubMed ID: 17761940
[TBL] [Abstract][Full Text] [Related]
14. Inner Mitochondrial Membrane Disruption Links Apoptotic and Agonist-Initiated Phosphatidylserine Externalization in Platelets.
Choo HJ; Kholmukhamedov A; Zhou C; Jobe S
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1503-1512. PubMed ID: 28663253
[TBL] [Abstract][Full Text] [Related]
15. CD36-fibrin interaction propagates FXI-dependent thrombin generation of human platelets.
Döhrmann M; Makhoul S; Gross K; Krause M; Pillitteri D; von Auer C; Walter U; Lutz J; Volf I; Kehrel BE; Jurk K
FASEB J; 2020 Jul; 34(7):9337-9357. PubMed ID: 32463151
[TBL] [Abstract][Full Text] [Related]
16. Platelet adhesion enhances the glycoprotein VI-dependent procoagulant response: Involvement of p38 MAP kinase and calpain.
Siljander P; Farndale RW; Feijge MA; Comfurius P; Kos S; Bevers EM; Heemskerk JW
Arterioscler Thromb Vasc Biol; 2001 Apr; 21(4):618-27. PubMed ID: 11304481
[TBL] [Abstract][Full Text] [Related]
17. Signaling role of CD36 in platelet activation and thrombus formation on immobilized thrombospondin or oxidized low-density lipoprotein.
Nergiz-Unal R; Lamers MM; Van Kruchten R; Luiken JJ; Cosemans JM; Glatz JF; Kuijpers MJ; Heemskerk JW
J Thromb Haemost; 2011 Sep; 9(9):1835-46. PubMed ID: 21696539
[TBL] [Abstract][Full Text] [Related]
18. Phosphoproteomic analysis of platelets activated by pro-thrombotic oxidized phospholipids and thrombin.
Zimman A; Titz B; Komisopoulou E; Biswas S; Graeber TG; Podrez EA
PLoS One; 2014; 9(1):e84488. PubMed ID: 24400094
[TBL] [Abstract][Full Text] [Related]
19. Dasatinib Inhibits Procoagulant and Clot Retracting Activities of Human Platelets.
Beke Debreceni I; Mezei G; Batár P; Illés Á; Kappelmayer J
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31683623
[TBL] [Abstract][Full Text] [Related]
20. Oxidized low-density lipoprotein-dependent platelet-derived microvesicles trigger procoagulant effects and amplify oxidative stress.
Wang H; Wang ZH; Kong J; Yang MY; Jiang GH; Wang XP; Zhong M; Zhang Y; Deng JT; Zhang W
Mol Med; 2012 Mar; 18(1):159-66. PubMed ID: 22064971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
